Vancouver, British Columbia–(Newsfile Corp. – June 22, 2020) – iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”) and its subsidiary, iCo Therapeutics Australia Pty Ltd., announced today… Read More
VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the pricing of… Read More
VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has… Read More
Eric brings over 30 years of experience in the development of biopharmaceuticals, cell therapies, and regenerative medicine products VANCOUVER, BC — Aspect Biosystems, a biotechnology platform company pioneering the microfluidic… Read More
– FDA grants Priority Review and sets PDUFA date of January 22, 2021 – VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the… Read More
